Oppilotech Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Oppilotech Ltd's estimated annual revenue is currently $1.9M per year.
- Oppilotech Ltd's estimated revenue per employee is $155,000
Employee Data
- Oppilotech Ltd has 12 Employees.
- Oppilotech Ltd grew their employee count by 0% last year.
Oppilotech Ltd's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder/CEO | Reveal Email/Phone |
Oppilotech Ltd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Oppilotech Ltd?
Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oppilotech Ltd News
2022-03-22 - Oppilotech and Evariste Technologies Announce Partnership ...
LONDON, March 16, 2022 /PRNewswire/ -- Oppilotech Ltd, a biotech specialising in systems biology and machine learning platforms to build...
2022-03-22 - Other news to note for March 17, 2022
Oppilotech Ltd., of London, entered a partnership with Evariste Technologies Ltd., of the U.K., to develop first-in-class antibacterial...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.2M | 12 | -20% | N/A |
#2 | $1M | 12 | 0% | N/A |
#3 | $1.5M | 12 | -45% | N/A |
#4 | $1M | 12 | -37% | N/A |
#5 | $1.6M | 12 | -8% | N/A |